Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Journal for Immunotherapy of Cancer
|
November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Erika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.
Journal of the American Chemical Society
|
May 10, 2012
Rendering protein-based particles transiently insoluble for therapeutic applications
Jing Xu, Jin Wang, J Christopher Luft, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects
Takuya Osada, Peter Berglund, Michael A Morse, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Elife
|
February 22, 2022
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Science Translational Medicine
|
August 7, 2024
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models
Nikole L Warner, Jacob Archer, Stephanie Park, et al.
Vaccine
|
October 27, 2007
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
Bolyn Hubby, Todd Talarico, Maureen Maughan, et al.
Vaccines
|
November 27, 2021
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes Dos Santos Fonseca, et al.
Iscience
|
April 15, 2025
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques
Sevasti Karaliota, Maha Moussa, Margherita Rosati, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 5, 2023
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M Leal, Adrian Simpson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Journal for Immunotherapy of Cancer
|
November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Erika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.
Journal of the American Chemical Society
|
May 10, 2012
Rendering protein-based particles transiently insoluble for therapeutic applications
Jing Xu, Jin Wang, J Christopher Luft, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects
Takuya Osada, Peter Berglund, Michael A Morse, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Elife
|
February 22, 2022
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Science Translational Medicine
|
August 7, 2024
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models
Nikole L Warner, Jacob Archer, Stephanie Park, et al.
Vaccine
|
October 27, 2007
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
Bolyn Hubby, Todd Talarico, Maureen Maughan, et al.
Vaccines
|
November 27, 2021
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes Dos Santos Fonseca, et al.
Iscience
|
April 15, 2025
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques
Sevasti Karaliota, Maha Moussa, Margherita Rosati, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 5, 2023
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M Leal, Adrian Simpson, et al.
Page
of 5